Companion Animal Zoonoses
Editor(s):
J. Scott Weese DVM, DVSc, DipACVIM,
Martha B. Fulford BSc, BEd, MA, MD, FRCPC,
First published:13 December 2010
Print ISBN:9780813819648 |Online ISBN:9780470958957 |DOI:10.1002/9780470958957
Copyright © 2011 Blackwell Publishing Ltd.

Navigation Bar
Menu
HOME
AUTHOR BIOGRAPHY
REVIEWS

About this book

Companion Animal Zoonoses is a comprehensive resource on diseases transmissible between animals and humans. Presenting detailed prevention and control strategies for zoonotic diseases, the book is an in-depth guide to practical information on the spread of disease between pet animals and humans. This relevant work provides up-to-date information on emerging issues, disease incidence and risk, and management measures.

Covering the complete range of companion animal zoonoses, each topic begins with information on etiology, geographic distribution, epidemiology, and pathophysiology. The discussion then moves into clinical presentation, diagnosis, and management, alongside prevention information for both animals and humans. Companion Animal Zoonoses is an essential reference for practicing veterinarians, public health veterinarians, and veterinary students. It will also appeal to physicians who wish to better understand zoonotic diseases

EXCERPT

Front Matter (Pages: i-ix)

• Summary
 
• PDF 
• 
  
• CHAPTER 3
• Viral Diseases (Pages: 241-274)
• • J. Scott Weese DVM, DVSc, DipACVIM
   
  • Martha B. Fulford BSc, BEd, MA, MD, FRCPC
  • Summary
   
  • PDF
   
  • References

  • 
    

  • Index (Pages: 317-319)

    • First Page
     
    • PDF
    • Request permissions
    • 
      
    • OTHER CHAPTERS
    • 
      
    • CHAPTER 1
    • 
      
    • Parasitic Diseases (Pages: 3-107)
    • 
      
    • CHAPTER 2
    • 
      
    • Bacterial Diseases (Pages: 109-240)
    • 
      
    • CHAPTER 4
    • 
      
    • Fungal Diseases (Pages: 275-298)
    • 
      
    • CHAPTER 5
    • 
      
    • Pets and Immuno compromised Individuals (Pages: 299-309)
    • 
      
    • CHAPTER 6
    • 
      
    • Pet Bites (Pages: 311-315)

CONTRARY TO DR. TRUMP 
THE CORONAVIRUS IS NOT INVISIBLE

CORONAVRIUS SARS MERS COVID-19

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov .
Get the latest research from NIH: https://www.nih.gov/coronavirus.

Zoonoses diseases

Laura Christie, MD Carol Glaser, MD, DVM 

California Department of Public Health 

Viral and Rickettsial Disease Laboratory 

Richmond, CA, USA 

Prepared as part of an education project of the 

Global Health Education Consortium and collaborating partners

PDF OF A PPT PRESENTATION

62 SLIDES

CORONAVRIUS SARS MERS COVID-19

Changing Patterns of Emerging Zoonotic Diseases in Wildlife, Domestic Animals, and Humans Linked to Biodiversity Loss and Globalization
A Alonso Aguirre
ILAR Journal,

Volume 58
Issue 3
2017

 Pages 315–318, https://doi.org/10.1093/ilar/ilx035

PDF

Abstract

The fundamental human threats to biodiversity including habitat destruction, globalization, and species loss have led to ecosystem disruptions altering infectious disease transmission patterns, the accumulation of toxic pollutants, and the invasion of alien species and pathogens. To top it all, the profound role of climate change on many ecological processes has affected the inability of many species to adapt to these relatively rapid changes. This special issue, “Zoonotic Disease Ecology: Effects on Humans, Domestic Animals and Wildlife,” explores the complex interactions of emerging infectious diseases across taxa linked to many of these anthropogenic and environmental drivers. Selected emerging zoonoses including RNA viruses, Rift Valley fever, trypanosomiasis, Hanta virus infection, and other vector-borne diseases are discussed in detail. Also, coprophagous beetles are proposed as important vectors in the transmission and maintenance of infectious pathogens. An overview of the impacts of climate change in emerging disease ecology within the context of Brazil as a case study is provided. Animal Care and Use Committee requirements were investigated, concluding that ecology journals have low rates of explicit statements regarding the welfare and wellbing of wildlife during experimental studies. Most of the solutions to protect biodiversity and predicting and preventing the next epidemic in humans originating from wildlife are oriented towards the developed world and are less useful for biodiverse, low-income economies. We need the development of regional policies to address these issues at the local level.

Article Contents
Abstract
Tick-Borne Zoonoses in the United States: Persistent and Emerging Threats to Human Health
Coprophagous Insects and the Ecology of Infectious Disease of Wildlife
Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review
RVF: Does Wildlife Play a Role?
The Animal Wildlife Act and the Conduct and Publishing of Wildlife Research in the United States
Toward an Ecological Framework for Assessing Reservoirs of Vector-Borne Pathogens: Wildlife Reservoirs of Trypanosoma cruzi across the Southern United States
The Impact of Global Environmental Changes on Infectious Disease Emergence with a Focus on Risks for Brazil
Species Identity Supersedes the Dilution Effect Concerning Hantavirus Prevalence at Sites across Texas and Mexico
References

Zoonoses 3 Prediction and prevention of the next pandemic zoonosis THE LANCET DECEMBER 1, 2012
Stephen S Morse, Jonna A K Mazet, Mark Woolhouse, Colin R Parrish, Dennis Carroll, William B Karesh, Carlos Zambrana-Torrelio, W Ian Lipkin, Peter Daszak
Most pandemics—eg, HIV/AIDS, severe acute respiratory syndrome, pandemic infl uenza—originate in animals, are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their substantial eff ects on global public health and growing understanding of the process by which they emerge, no pandemic has been predicted before infecting human beings. We review what is known about the pathogens that emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their control and new eff orts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from response to pre-emption.


Brazilian Journal of Infectious DiseasesPrint version ISSN 1413-8670On-line version ISSN 1678-4391
Braz J Infect Dis vol.22 no.1 Salvador Jan./feb. 2018
https://doi.org/10.1016/j.bjid.2017.11.003

LETTERS TO THE EDITOR

Zoonotic spillover and emerging viral diseases – time to intensify zoonoses surveillance in Brazil
Joel Henrique Ellwanger1
José Artur Bogo Chies* 1

1Laboratório de Imunobiologia e Imunogenética, Programa de Pós-Graduação em Genética e Biologia Molecular, Departamento de Genética, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil

Dear Editor:
Are we prepared to face newly emerging viral diseases? This question is as recurrent as the emergence of new viruses and the reemergence of neglected infectious diseases. Of note, Central and South America are considered world hotspots for the emergence of new mammalian viral zoonoses.1 Due to the size of its territory, Brazil lies at the center of these hotspots.

Zoonotic Diseases of Public Health Importance - NCDC

https://ncdc.gov.in › WriteReadData › File618

new and emerging zoonotic diseases, like Ebola, Zika Virus Disease and ... Besides serving as a reference book, the ... situation-report-12-02-2016.pdf).

UP TO DATE REFERENCE MANUAL FROM INDIA 2016

A brief guide to emerging infectious diseases and zoonoses
A brief guide to emerging infectious diseases and zoonoses.
1. Communicable Diseases, Emerging
2. Zoonoses – epidemiology – prevention and control.
3. Virus Diseases.
4. Bacterial Infections. 
5. Parasitic Diseases. 
6. Pest Control
ISBN 978-92-9022-458-7(NLM classification: WA 110

© World Health Organization 2014
All rights reserved.Requests for publications, or for permission to reproduce or translate WHO publications – whether for sale orfor noncommercial distribution – can be obtained from SEARO Library, World Health Organization, RegionalOffice for South-East Asia, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi 110 002, India (fax: +91 1123370197; e-mail: searolibrary@who.int).

Bats and Viruses - Journal of Wildlife Diseases

https://www.jwildlifedis.org › doi › pdf

by AT Gilbert - ‎2017 - ‎Related articles

Book reviews express the opinions of the individual authors regarding the value of the book's ... zoonosis. The potential for aerosol transmis- sion of rabies virus from massive aggregations ... the recent popular book Spillover (Quammen.

SPILLOVER: ANIMAL INFECTIONS AND THE NEXT HUMAN PANDEMIC

(PDF) Spillover: Animal Infections and the Next Human ...

https://www.researchgate.net › publication › 279755005_Spillover_Anima...

These diseases can't be well understood. until the principles of zoonotic spillover are. understood. Secondly, a large part of my book is de-. voted to these big ...

AUTHOR INTERVIEW 

THE AUTHOR OF SPILLOVER IS A SCIENCE JOURNALIST
“Intrepid disease ecologists are hiking into forests, climbing through caves,… and sleuthing the mysteries of reservoir host and spillover.” David Quammen
THE ROYAL SCOTTISH GEOGRAPHICAL SOCIETY JOURNAL
Winter 2013 -14 Zoonoses Reservoirs, reasons and the role of viruses • RSGS’s First ‘Explorer-in Residence’ • Zoonotic Geographies – A Multi-Faceted Issue • Viruses, Evolution & Spillover • Living Patterns, Vaccines & Vermin •

Book
 A journey of zoonotic discovery
 Many of the students I teach will no doubt enjoy David Quammen’s Spillover: Animal Infections and the Next Human Pandemic; they are always excited about patients haemorrhaging blood everywhere, there being no cure, and the arguments about what happens next. Quammen’s fast-paced book tracks various zoonotic pathogens across the globe as he tells the contrasting stories of, among others, Hendra virus infection, the viral haemorrhagic fevers caused by Marburg or Ebola virus, severe acute respiratory syndrome (SARS), and HIV/AIDS. Quammen makes it clear from the outset that if we are to halt this epidemic of zoonotic cases we must stop destroying natural ecosystems at a “cataclysmic rate”. And it’s from this perspective that Quammen relates his account of these viruses, making the point that “It’s not that they target us especially. It’s just that we are so obtrusively, abundantly available.” Readers will be enthralled by his tales of tramping into caves looking for bats and pythons and even the odd cobra, or feeding gorillas in central Africa. Quammen does this well, keeping back from the action and documenting his encounters with the experts. We follow the author as he interviews scientists, survivors, and local people in horse farms, jungles, and high-biosecurity laboratories in such countries as Bangladesh, the Congo, and China. As we travel alongside him, we realise that each chapter is essentially a mixture of news and research fi ndings, with interviews and travelogue thrown in.

GUNS , GERMS, AND STEEL

PDF COPY
https://archive.org/details/fp_Jared_Diamond-Guns_Germs_and_Steel

Guns, Germs, and Steel - eScholarship@UMMS

escholarship.umassmed.edu › cgi › viewcontent

PDF

by H Fenigsohn - ‎2011 BOOK REVIEW

Jared Diamond, Guns, Germs, and Steel: The Fates of Human Societies (W.W. Norton &. Company), 1997. Reviewed November 2011 by Harvey Fenigsohn.

DVD

https://www.amazon.com/National-Geographic-Special-Presentation-Germs/dp/0792292553

How coronavirus turned a 'niche market' into a necessity for the world's doctors

Curogram COO: We're seeing unprecedented demand for telemedicine in this crisis

Brooke DiPalma Associate Producer Yahoo Finance 29 March 2020

As coronavirus, or COVID-19, continues to spread with nearly 680,000 confirmed cases worldwide as of Saturday morning, telemedicine is seeing an unprecedented demand as physicians see more patients remotely, according to industry executives.

The COO of Curogram — a HIPAA-compliant online platform that allows patients and doctors to text and meet through a “virtual online clinic” — says his team is “literally” working 20 hours a day amid the increased demand due to the pandemic.

“As you can imagine telemedicine a month ago was a niche market with minimal demand,” Curogram COO Michael Hsu told Yahoo Finance’s The First Trade on Friday. “And overnight it has become a need of every doctor in the country and the world.”
‘We have more than tripled our staff’

Meanwhile, demand for Doxy.me — a free, HIPAA-compliant, product that allows doctors and patients to video chat — has “increased a thousandfold,” according to its founder, Brandon Welch.

“We have more than tripled our staff in the last month,” Welch told Yahoo Finance, in order to meet the demand for doctors to have the “immediate ability” to see their patients remotely.

More doctors may be seeing patients remotely for the foreseeable future. Image: Getty

Due to the contagion of the new virus, countries and cities around the world have implemented mandatory lockdowns, and more and more physicians — as well as psychotherapists — are seeing their patients remotely. The American Medical Association (AMA) has noted that remote health care — either through the phone, email, or other means — can play a major role in giving patients access to care during a pandemic.

Services like Doxy.me and Curogram allow medical professionals and therapists to comply with the Health Insurance Portability and Accountability Act, or HIPAA, which protects patient privacy.

On Friday, President Donald Trump signed a $2 trillion coronavirus stimulus package that makes it easier for doctors to see patients remotely — in part by increasing telehealth coverage under Medicare, according to the AMA.

The American Telemedicine Association commended the bill for increasing access to remote medical care, saying it will provide “much-needed support to America’s health care providers who are migrating patients to virtual care platforms to reduce exposure to COVID-19.”

While telemedicine is particularly crucial during a viral outbreak, Curogram COO Michael Hsu contends the medical industry is seeing a “paradigm shift” with regards to telemedicine that could be long-lasting.

In the future, Hsu says we’ll see a “vast majority of doctors shifting maybe upwards of 25% to even 50% of their volume to telemedicine.” Amid an economic downturn that saw over 3 million jobless claims reported last week, his company is now hiring.

---30---

Britain orders 10,000 ventilators in fight against coronavirus -source

By Costas Pitas Reuters29 March 2020

LONDON (Reuters) - Britain has placed an order for 10,000 ventilators to be made by a consortium of companies including Ford , Airbus and Rolls-Royce as part of efforts to fight the coronavirus, an industry source told Reuters.

Governments around the world are trying to boost the number of ventilators - mechanical breathing devices that can blow air and oxygen into the lungs - available to their health services.

The equipment is crucial for the care of people who suffer lung failure, which can be one of the complications suffered by patients with severe COVID-19, the disease caused by the coronavirus. But they do not necessarily save people.

An announcement is due on Monday, the source said.

British media previously reported the news. A spokeswoman at Prime Minister Boris Johnson's Downing Street office declined to offer an immediate comment when contacted by Reuters.

Britain's publicly funded National Health Service has a little more than 8,000 ventilators at its disposal, senior government minister Michael Gove said on Sunday.

The government is boosting capacity through agreements made with the private sector and overseas suppliers as well as domestic production.

"We've done a deal with (vacuum cleaner company) Dyson, which means that - provided all the appropriate tests are passed - we can have an additional 10,000 ventilators," Gove said.

"There are other companies, from McLaren to Rolls-Royce and others, who are changing the way in which they manufacture in order to join in the national effort to increase the ventilator capacity available."

McLaren said its Formula One car-making, data and electronics operations are fulfilling a number of tasks to help with the crisis, including making components.

"McLaren Automotive is facilitating duplicating and expanding the production of existing devices to meet demand ...(and) is designing bespoke trolleys on which the ventilators are fixed for use in clinical settings."




(Reporting by Costas Pitas; Editing by Louise Heavens and David Goodman)